Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging Options

,
Pharmacy Times, June 2015 Women's Health, Volume 81, Issue 6

This Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.

This activity is supported by an educational grant from sanofi-aventis U.S.

Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging Options

Faculty

Jennifer M. Trujillo, PharmD, BCPS, CDE

Associate Professor

University of Colorado

Skaggs School of Pharmacy and

Pharmaceutical Sciences

Aurora, CO

Wesley Nuffer, PharmD, BCPS, CDE

Assistant Professor

Assistant Director of Experiential

Programs

University of Colorado

Skaggs School of Pharmacy and

Pharmaceutical Sciences

Aurora, CO

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Discuss why postprandial hyperglycemia and hypoglycemia occur with existing prandial therapies.
  • Review the pharmacokinetic and pharmacodynamic profile, efficacy, and safety of available prandial therapies, as well as those in development.
  • Discuss the role of prandial therapies in addressing patient therapeutic needs, as well as the importance of counseling patients on safe and effective drug therapy use.

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

June 7, 2015

Expiration date:

June 7, 2017

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-054-H01-P. The activity is available for CE credit through June 7, 2017.